Why the study?
The relationship between pulmonary vein ostial unipolar voltage and left atrial wall thickness, and their utility as outcome indices after AF ablation, remains unclear.
Does the combination of unipolar voltage and left atrial wall thickness predict atrial tachyarrhythmia recurrence in patients undergoing atrial fibrillation ablation?
Does the combination of unipolar voltage and left atrial wall thickness predict atrial tachyarrhythmia recurrence in patients undergoing atrial fibrillation ablation?
Combining unipolar voltage and left atrial wall thickness can stratify recurrence risk and guide tailored ablation strategies in patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
LAH-LUV may stratify ATA recurrence risk after AF ablation; hypothesis-generating and requires prospective validation before guiding practice.
AIMS: The relationship between local unipolar voltage (UV) in the pulmonary vein (PV)-ostia and left atrial wall thickness (LAWT) and the utility of these parameters as indices of outcome after atrial fibrillation (AF) ablation remain unclear. METHODS AND RESULTS: Two-hundred seventy-two AF patients who underwent AF ablation were enrolled. Unipolar voltage of PV-ostia was measured using a CARTO system, and LAWT was measured using computed tomography. The primary endpoint was atrial tachyarrhythmia (ATA) recurrence including AF. The ATA recurrence was documented in 74 patients (ATA-Rec group). The UV and LAWT of the bilateral superior PV roof to posterior and around the right-inferior PV in the ATA-Rec group were significantly greater than in patients without ATA recurrence (ATA-Free group) (P < 0.001). The UV had a strong positive correlation with LAWT (R2 = 0.446, P < 0.001). The UV 2.7 mV and the corresponding LAWT 1.6 mm were determined as the cut-off values for ATA recurrence (P < 0.001, respectively). Multisite LA high UV (HUV, ≥4 areas of >2.7 mV) or multisite LA wall thickening (≥5 areas of >1.6 mm), defined as LA hypertrophy (LAH), was related to higher ATA recurrence. Among 92 LAH patients, 66 had HUV (LAH-HUV) and the remaining 26 had low UV (LAH-LUV), characterized by history of non-paroxysmal AF and heart failure, reduced LV ejection fraction, or enlarged LA. In addition, LAH-LUV showed the worst ablation outcome, followed by LAH-HUV and No LAH (log-rank P < 0.001). CONCLUSION: Combining UV and LAWT enables us to stratify recurrence risk and suggest a tailored ablation strategy according to LA tissue properties.
No takes yet. Share an insight, caveat, or question.
Kamioka et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: